Galecto Inc
NASDAQ:GLTO
Galecto Inc
Cash from Operating Activities
Galecto Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Cash from Operating Activities
-$36.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Cash from Operating Activities
kr7.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Cash from Operating Activities
-kr425.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-10%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Cash from Operating Activities
-€467.4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Cash from Operating Activities
kr1.1B
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
22%
|
Bioporto A/S
CSE:BIOPOR
|
Cash from Operating Activities
-kr55.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-13%
|
See Also
What is Galecto Inc's Cash from Operating Activities?
Cash from Operating Activities
-36.9m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Cash from Operating Activities amounts to -36.9m USD.
What is Galecto Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-22%
Over the last year, the Cash from Operating Activities growth was 14%. The average annual Cash from Operating Activities growth rates for Galecto Inc have been 1% over the past three years , -22% over the past five years .